Completed PHASE3 INTERVENTIONAL 1-arm NCT01856413

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant (ZEUS)

An Open, Prospective, Single Arm Study Investigating Efficacy and Safety of Human Hepatitis B Immunoglobulin Zutectra in Liver Transplanted Patients - the ZEUS Study

Sponsor: AMS Advanced Medical Services GmbH

Conditions Hepatitis B

Interventions Zutectra

Updated 6 times since 2017 Last updated: Mar 24, 2015 Started: Dec 31, 2012 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Hepatitis B, this trial is completed. The trial is conducted by AMS Advanced Medical Services GmbH and has accumulated 6 data snapshots since 2012. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AMS Advanced Medical Services GmbH
Biotest

Data source: Biotest

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Barcelona, Spain , Bari, Italy , Birmingham, United Kingdom , Bologna, Italy , Cagliari, Italy , London, United Kingdom , Lyon, France , Madrid, Spain , Milan, Italy , Modena, Italy and 5 more locations